Discontinuation of Rare Disease Testing at LifeLabs Genetics
Starting May 2, 2022, LifeLabs Genetics will no longer offer genetic tests related to Rare Disease diagnosis. However, we continue to expand our genetic test offerings in other areas, such as reproductive health, wellness, oncology and risk assessment and testing, ...
IMPORTANT UPDATE FOR PATIENTS AND CLINICS IN ONTARIO ONLY
On December 17, 2021, BORN announced NIPT for twin pregnancies, regardless of maternal age, gestational age or other factors, is now funded by the Ministry of Health. The new guidelines improve access to prenatal screening and are applicable to LifeLabs’ Panorama™ ...
FastTRK is a clinical testing program for the diagnosis of NTRK gene fusions. Sponsored by Bayer, this is a complimentary service for clinicians to determine whether their patients’ cancer has an NTRK gene fusion.
Eligibility criteria includes ALL patients with solid tumours that are metastatic or ...
UPDATE: EXTENDED TO MARCH 31, 2022
IMPORTANT UPDATE FOR PATIENTS AND CLINICS IN ONTARIO ONLY
New, temporary criteria for Non-Invasive Prenatal Testing in Ontario will improve access to NIPT: The COVID-19 crisis has reduced patient access to ultrasounds for nuchal translucency measurement used along with the enhanced first trimester screen ...
Non-Invasive Prenatal Testing 
Hereditary Cancer 
Search for a Test 
